Celularity Inc Stock Ownership - Who owns Celularity?

Insider buying vs selling

Have Celularity Inc insiders been buying or selling?
Kyle FletcherExecutive Vice President General Counsel2024-04-1320$4.11
Stephen BrigidoPres Functional Regeneration2024-04-13268$4.11
John R. HainesSenior EVP Chief Administrative Officer2024-04-13576$4.11
Robert J. HaririChief Executive Officer2024-04-131,154$4.11
David C. BeersChief Financial Officer2024-04-13360$4.11
Kyle FletcherExecutive Vice President General Counsel2024-03-15617$5.68
David C. BeersChief Financial Officer2024-02-1743,968$0.43
Stephen BrigidoPres Functional Regeneration2024-02-1732,720$0.43
Kyle FletcherExecutive Vice President General Counsel2024-02-1739,571$0.43
John R. HainesSenior EVP Chief Administrative Officer2024-02-1770,350$0.43

1 of 2

CELU insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CELU insiders and whales buy or sell their stock.

CELU Shareholders

What type of owners hold Celularity Inc stock?
Kok Thay Lim420.95%81,572,685$240.64MInsider
Dragasac Ltd155.14%30,062,778$88.69MInsider
Starr International Co Inc78.86%15,281,389$45.08MInsider
Sorrento Therapeutics Inc26.06%5,050,427$14.90MInsider
Robert J. Hariri14.74%2,855,889$8.42MInsider
Jay R. Bloom9.09%1,761,253$5.20MInsider
Peter Diamandis6.75%1,307,066$3.86MInsider
Adrian Kilcoyne5.79%1,122,238$3.31MInsider
John Sculley5.18%1,004,660$2.96MInsider
Dean C. Kehler3.77%730,442$2.15MInsider

1 of 3

CELU vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CELU0.58%99.42%Net Buying
TECX44.62%55.38%Net BuyingNet Buying
SLS13.36%13.33%Net Selling

Celularity Stock Ownership FAQ

Who owns Celularity?

Celularity (NASDAQ: CELU) is owned by 4.30% institutional shareholders, 734.91% Celularity insiders, and 0.00% retail investors. Kok Thay Lim is the largest individual Celularity shareholder, owning 81.57M shares representing 420.95% of the company. Kok Thay Lim's Celularity shares are currently valued at $260.22M.

If you're new to stock investing, here's how to buy Celularity stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.